TolerogenixX
Latest round
- Seed
Last raised
- May 2017
Total raised
- Undisclosed
Investors
- 1
About TolerogenixX
Founded in 2016, TolerogenixX GmbH specializes in innovative cellular therapies.TolerogenixX GmbH specializes in the development of personalized cellular therapies aimed at achieving sustained immune tolerance, primarily for organ transplant recipients and patients with autoimmune diseases. Their flagship product, MIC-Lx (Modified Immune Cells for Living-donor transplants), utilizes proprietary MIC technology to modify peripheral blood mononuclear cells (PBMCs) from living donors. This therapy aims to induce donor-specific immune tolerance, thus minimizing organ rejection risks and the need for long-term immunosuppression. The company's revenue generation primarily stems from partnerships with healthcare institutions and clinical centers that administer its MIC-Lx therapy. Future product launches are being designed to enhance patient outcomes, with a focus on maintaining a robust clinical development strategy.
Who invested in TolerogenixX
1 investor across 1 round
See all investors in TolerogenixX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 23, 2017
Amount
Undisclosed
Investors
Questions about TolerogenixX
Who invested in TolerogenixX?
TolerogenixX has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TolerogenixX raised?
TolerogenixX has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did TolerogenixX last raise money?
TolerogenixX's most recent round on record is a Seed, in May 2017.
What does TolerogenixX do?
Founded in 2016, TolerogenixX GmbH specializes in innovative cellular therapies.
Where is TolerogenixX headquartered?
TolerogenixX is headquartered in Heidelberg, Germany.
Which VCs invest in companies like TolerogenixX?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at TolerogenixX's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like TolerogenixX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.